Safety Profile
Information not yet available for this ingredient profile.
Interactions
Information not yet available for this ingredient profile.
Evidence and Scientific Findings
Ingredient Overview
Oat flour is ground whole oat grain used as a carbohydrate source in supplements. Excellent safety record. Use certified gluten-free oat flour for coeliac individuals.
Biological and Chemical Classification
- Scientific Name
- Avena sativa
Mechanism of Action
Information not yet available for this ingredient profile.
Clinical Evidence of Effectiveness
Information not yet available for this ingredient profile.
Pharmacokinetics
Information not yet available for this ingredient profile.
Recommended Dosage
Information not yet available for this ingredient profile.
SETI — Scientific Evidence Transparency Index
Executive Summary — Ingredient Assessment
- 10 studies reviewed
- 0 high-quality studies (meta-analysis or RCT)
- Main clinical benefit observed: Specialty
- Evidence consistency: High consistency across studies (100%)
- No significant safety signals identified in the reviewed literature.
The available scientific evidence for Oat Flour indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.
Total SETI Score
High risk| Evidence quality | 10/40 |
| Evidence consistency | 20/20 |
| Safety signals | 0/20 |
| Study recency | 10/10 |
| Evidence transparency | 10/10 |
Evidence Summary
- 10 studies reviewed
- 0 high-quality studies (meta-analysis or systematic review)
- 0 studies identified benefits or no safety concern (GREEN)
- 10 studies reported limited or advisory safety evidence (YELLOW)
Evidence Policy
Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.
Last updated: 06 ივნ 2026, 12:04
Evidence Distribution
-
Observational / other LOW evidence YELLOWRevisiting oat composition, functional and thermal properties, and processing strategies for enhanced nutritional and functional performance. ↗Bereka TY et al.. Revisiting oat composition, functional and thermal properties, and processing strategies for enhanced nutritional and functional performance.. J Sci Food Agric. 2026. PMID:42227641.PMID 42227641 ↗Journal J Sci Food AgricYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42227641/
-
Observational / other LOW evidence YELLOWMetabolomic insights reveal bioactive enhancement in fermented oat-based beverages via Lactobacillus plantarum. ↗Castillo A et al.. Metabolomic insights reveal bioactive enhancement in fermented oat-based beverages via Lactobacillus plantarum.. Food Funct. 2026. PMID:42212452.PMID 42212452 ↗Journal Food FunctYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42212452/
-
Observational / other LOW evidence YELLOWAlfalfa Rotation Enhances Soil Microbial Diversity and Reduces Tilletia foetida DNA Abundance in Common Bunt-Infected Wheat Fields. ↗Chen D et al.. Alfalfa Rotation Enhances Soil Microbial Diversity and Reduces Tilletia foetida DNA Abundance in Common Bunt-Infected Wheat Fields.. Plant Pathol J. 2026. PMID:42210638.PMID 42210638 ↗Journal Plant Pathol JYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42210638/
-
Observational / other LOW evidence YELLOWThe role of endogenous hormones in regulating grain number in oat panicles under drought stress across cultivars. ↗Li J et al.. The role of endogenous hormones in regulating grain number in oat panicles under drought stress across cultivars.. Front Plant Sci. 2026. PMID:42179487.PMID 42179487 ↗Journal Front Plant SciYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42179487/
-
Observational / other LOW evidence YELLOWYield and nitrogen use efficiency in optimized oat-common vetch mixtures on the Qinghai-Tibet plateau. ↗Bao M et al.. Yield and nitrogen use efficiency in optimized oat-common vetch mixtures on the Qinghai-Tibet plateau.. Front Plant Sci. 2026. PMID:42125610.PMID 42125610 ↗Journal Front Plant SciYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42125610/
-
Observational / other LOW evidence YELLOWEffects of Allium fistulosum L. (Green Onion) Root and Avena sativa L. (Oat) Mixtures (WCO31) on the Height of Children: A Multi-Center,… ↗Kim YJ et al.. Effects of Allium fistulosum L. (Green Onion) Root and Avena sativa L. (Oat) Mixtures (WCO31) on the Height of Children: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. Nutrients. 2026. PMID:42123928.PMID 42123928 ↗Journal NutrientsYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42123928/
-
Observational / other LOW evidence YELLOWGenome-Wide Identification and Characterization of the 14-3-3 Gene Family in Avena sativa. ↗Xu S et al.. Genome-Wide Identification and Characterization of the 14-3-3 Gene Family in Avena sativa.. Plants (Basel). 2026. PMID:42122774.PMID 42122774 ↗Journal Plants (Basel)Year 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42122774/
-
Observational / other LOW evidence YELLOWPhysicochemical Properties, Rheological Characteristics, Flavor Profile and Antioxidant Activity of Fermented Plant-Based Alternative to Yoghurt from Avena sativa L. and Prunus dulcis… ↗Ma M et al.. Physicochemical Properties, Rheological Characteristics, Flavor Profile and Antioxidant Activity of Fermented Plant-Based Alternative to Yoghurt from Avena sativa L. and Prunus dulcis (Mill.) D. A. Webb.. Foods. 2026. PMID:42121473.PMID 42121473 ↗Journal FoodsYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42121473/
-
Observational / other LOW evidence YELLOWWhole-genome analysis reveals the growth-promoting and biocontrol potential of Bacillus amyloliquefaciens Ba. YN.J3 isolated from Avena Sativa. ↗Quan W et al.. Whole-genome analysis reveals the growth-promoting and biocontrol potential of Bacillus amyloliquefaciens Ba. YN.J3 isolated from Avena Sativa.. BMC Genomics. 2026. PMID:42108430.PMID 42108430 ↗Journal BMC GenomicsYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42108430/
-
Observational / other LOW evidence YELLOWDivergent rhizosphere microbial necromass dynamics between two plant species in response to water addition in a semi-arid region. ↗Yang Y et al.. Divergent rhizosphere microbial necromass dynamics between two plant species in response to water addition in a semi-arid region.. Sci Rep. 2026. PMID:42108317.PMID 42108317 ↗Journal Sci RepYear 2026Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/42108317/
Score Transparency
0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.
Method: Q = number of approved references ÷ 10 (capped at 1.0)
Limited — mostly case reports or animal studies
Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.
Mixed or neutral — roughly equal benefit and risk signals
Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.
One or more monitoring-level safety signals active
Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.
Final GIRI Score for Oat Flour. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
Full methodology & data sources
The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.
- References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
- Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
- Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
- Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
Risk Level Classification
Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.
0–3.0
3.0–5.5
5.5–7.5
7.5–10
The score pin shows exactly where this ingredient falls on the fixed risk scale.
What drove the Low classification for Oat Flour
A score of 1.0 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
0 approved references.
Limited — mostly case reports or animal studies (Level 4–5).
Neutral or mixed — benefit and risk signals roughly balanced.
No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.
No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).
How are the Low / Moderate / High / Critical thresholds defined?
The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:
| Level | Score | Meaning |
|---|---|---|
| LOW | 0.0 – 2.9 | Sparse or predominantly beneficial evidence. No active safety alerts. |
| MODERATE | 3.0 – 5.4 | Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups. |
| HIGH | 5.5 – 7.4 | Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended. |
| CRITICAL | 7.5 – 10 | Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision. |
Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.